Tumor suppressor p53 gene mutation in squamous cell carcinoma of the larynx

Diagnostic Molecular Pathology

Volumn 5, Issue 3, 1996, Pages 201-205

  Sarkar, Fazlul H ^a   Sakr, Wael A ^a   Li, Yi Wei ^a,b   Jacobs, John ^a   Crissman, John D ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Department of Dermatology   (China)

Author keywords

Gene mutations; Laryngeal carcinoma; p53 Gene; Polymerase chain reaction; Tumor suppressor gene

Indexed keywords

PROTEIN P53;

ARTICLE; CANCER GENETICS; DNA SEQUENCE; GENE MUTATION; HUMAN; HUMAN TISSUE; LARYNX CARCINOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SINGLE STRAND CONFORMATION POLYMORPHISM; SQUAMOUS CELL CARCINOMA; TUMOR SUPPRESSOR GENE;

CARCINOMA, SQUAMOUS CELL; GENES, P53; HUMANS; LARYNGEAL NEOPLASMS; MUTATION; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 0029789169     PISSN: 10529551     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019606-199609000-00009     Document Type: Article

References (26)

1. Baker SJ, Preisinger AC, Jessup JM, et al. p53 gene mutations occur in combination with 17p allelic deletions as late events in colorectal tumorigenesis. Cancer Res 1990;50: 7717-22.
2. Boring CC. Cancer statistics. CA Cancer J Clin 1994;44:7-26.
3. Boyle JO, Hakim J, Koch W, et al. The incidence of p53 mutations increases with progression of head and neck cancer. Cancer Res 1993;53:4477-80.
4. Chiba I, Takahashi T, Nan MM, et al. Mutations in the p53 gene are frequent in primary, resected non-small cell lung cancer. Oncogene 1990;5:1603-10.
5. Field JK, Spandidos DA, Malliri A, Gosney JR, Yiagnisis M, Stell PM. Elevated p53 expression correlates with a history of heavy smoking in squamous cell carcinoma of the head and neck. Br J Cancer 1991;64:573-7.
6. Fouret P, Dabit D, Sibony M, et al. Expression of p53 protein related to the presence of human papillomavirus infection in precancer lesions of the larynx. Am J Pathol 1995; 146:599-604.
7. Frankel R, Bayona W, Koslow M, Newcomb EW. p53 mutations in human malignant gliomas: comparison of loss of heterozygosity with mutation frequency. Cancer Res 1992; 52:1427-33.
8. Fujimoto K, Yamada Y, Okajima E, et al. Frequent association of p53 gene mutation in invasive bladder cancer. Cancer Res 1992;52:1393-8.
9. Hollstein MC, Peri L, Mandard AM, et al. Genetic analysis of human esophageal tumors from two high incidence geographic areas: frequent p53 base substitutions and absence of ras mutations. Cancer Res 1991;51:4102-6.
10. Hollstein M, Sidransky D, Vogelstein B, Harris CC. p53 mutations in human cancers. Science 1991;253:49-53.
11. Iggo R, Atter K, Bartek J, Lane D, Harris AL. Increased expression of mutant forms of p53 oncogene in primary lung cancer. Lancet 1990;335:675-9.
12. Ito T, Seyama T, Mizuno T, et al. Unique association of p53 mutations with undifferentiated but not with differentiated carcinomas of the thyroid gland. Cancer Res 1992;52:1369-71.
13. Knudson AG. Hereditary cancer, oncogenes, and antioncogenes. Cancer Res 1985;45:1437-43.
14. Levine AJ, Momand J, Finlay CA. The p53 tumor suppressor gene. Nature 1991;351:453-6.
15. Maestro R, Dolcetti R, Gasparotto D, et al. High frequency of p53 gene alterations associated with protein overexpression in human squamous cell carcinoma of the larynx. Oncogene 1992;7:1159-66.
16. Meek D. Post-translational modification of p53. Semin Cancer Biol 1994;5:203-10.
17. Milner J. Forms and functions of p53. Semin Cancer Biol 1994;5:211-9.
18. Nadal A, Campo E, Pinto J, et al. p53 expression in normal, dysplastic, and neoplastic laryngeal epithelium. Absence of a correlation with prognostic factors. J Pathol 1995;175: 181-8.
19. Nigro JM, Baker SJ, Preisinger AC, et al. Mutations in the p53 gene occur in diverse human tumor types. Nature 1989; 342:705-8.
20. Ohgaki H, Eibl RH, Wiestler OD, Yasargil MG, Newcomb EW, Kleihues P. p53 mutations in non-astrocytic human brain tumors. Cancer Res 1991;51:6202-5.
21. Sarkar FH, Li Y-W, Crissman JD. A method for PCR sequencing of the p53 gene from a single 10 μm frozen or paraffin-embedded tissue section. Biotechniques 1993;15: 36-7.
22. Scorsone KA, Zhou Y, Butel JS, Slagle BL. p53 mutations cluster at codon 249 in hepatitis B virus-positive hepatocellular carcinomas from china. Cancer Res 1992;52:1635-8.
23. Somers KD, Merrick MA, Lopez ME, Incognito LS, Schechter GL, Casey G. Frequent p53 mutations in head and neck cancer. Cancer Res 1992;52:5997-6000.
24. Wikland EM, Edstrom S, Jungmark E, Kuylenstierna R, Lindholm J, Auer G. Nuclear DNA content, proliferating-cell nuclear antigen (PCNA) and p53 immunostaining in predicting progression of laryngeal cancer in situ lesions. Int J Cancer 1994;56:950-99.
25. Xu L, Chen Y-T, Huvos AG, Zlotolow IM, Rettig WJ, Old LJ, Garin-Chesa P. Overexpression of p53 protein in squamous cell carcinoma of the head and neck without apparent gene mutations. Diagn Mol Pathol 1994;3:83-92.
26. Zang L-F, Hemminki K, Szyfter K, Szyfter W, Soderkvist P. P53 mutations in larynx cancer. Carcinogenesis 1994;15: 2949-51.